Original Research

Published on 14 Sep 2022

Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review

in Thoracic Oncology

Guohua Jia
Shuimei Zhou
Tangpeng Xu
Yabing Huang
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.954685

2,117 views
1 citation

Case Report

Published on 14 Sep 2022

Drug-induced liver injury associated with dacomitinib: A case report

in Thoracic Oncology

Xuanxuan Wang
Anqi Huang
Yun Lu
Suyu Gao
Wen Hu
Hong Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.979462

1,772 views
5 citations

Original Research

Published on 14 Sep 2022

The combined role of PET/CT metabolic parameters and inflammatory markers in detecting extensive disease in small cell lung cancer

in Thoracic Oncology

Yao Hu
Jin Sun
Danming Li
Yangyang Li
Tiannv Li
Yuxiao Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.960536

1,816 views
1 citation

Brief Research Report

Published on 13 Sep 2022

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases

in Thoracic Oncology

Xin Li
Chunqiu Xia
Minghui Liu
Jinghao Liu
Ming Dong
Honglin Zhao
Song Xu
Dan Wang
Sen Wei
Zuoqing Song

Frontiers in Oncology

doi 10.3389/fonc.2022.843116

1,957 views
1 citation

Original Research

Published on 13 Sep 2022

A detection panel of novel methylated DNA markers for malignant pleural effusion

in Thoracic Oncology

Chaonan Liang
Nan Liu
Qin Zhang
Mingming Deng
Jiangwei Ma
Jingwen Lu
Yan Yin
Jian Wang
Yuan Miao
Bin She

Frontiers in Oncology

doi 10.3389/fonc.2022.967079

2,610 views
7 citations

Original Research

Published on 09 Sep 2022

Pembrolizumab monotherapy for untreated PD-L1-Positive non-small cell lung cancer in the elderly or those with poor performance status: A prospective observational study

in Thoracic Oncology

Shinsuke Shiotsu
Akihiro Yoshimura
Tadaaki Yamada
Kenji Morimoto
Michiko Tsuchiya
Hiroshige Yoshioka
Osamu Hiranuma
Yusuke Chihara
Takahiro Yamada
Isao Hasegawa

Frontiers in Oncology

doi 10.3389/fonc.2022.904644

5,559 views
9 citations

Case Report

Published on 08 Sep 2022

Use of savolitinib as neoadjuvant therapy for non–small cell lung cancer patient with MET exon 14 skipping alterations: A case report

in Thoracic Oncology

Yu Zhang
Hao Zhang
Hanqing Wang
Jingtong Zeng
Bo Zhang
Ning Zhou
Lingling Zu
Zuoqing Song
Changli Wang
Song Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.968030

2,343 views
2 citations

Brief Research Report

Published on 07 Sep 2022

Impact of the interval between neoadjuvant immunochemotherapy and surgery on surgical–pathological outcomes in non-small cell lung cancer

in Thoracic Oncology

Jiawei Chen
Hongsheng Deng
Jiaxi He
Zhufeng Wang
Shuben Li

Frontiers in Oncology

doi 10.3389/fonc.2022.909726

2,259 views
5 citations

Original Research

Published on 05 Sep 2022

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy

in Thoracic Oncology

Ping Chen
Qing Yang
Yinfeng Li
Xiaomei Jing
Jing Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.894656

3,401 views
8 citations

Case Report

Published on 05 Sep 2022

EML4-ALK rearrangement in primary malignant fibrous histiocytoma of the lung treated with alectinib: A case report

in Thoracic Oncology

Shuai Zhang
Xuqiang Liao
Jiawei Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.978327

1,011 views
1 citation

Original Research

Published on 02 Sep 2022

Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study

in Thoracic Oncology

Yong-sheng Cai
Hong-hong Dong
Xin-yang Li
Xin Ye
Shuo Chen
Bin Hu
Hui Li
Jin-bai Miao
Qi-rui Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.976988

1,827 views

Original Research

Published on 02 Sep 2022

Deep learning analysis to predict EGFR mutation status in lung adenocarcinoma manifesting as pure ground-glass opacity nodules on CT

in Thoracic Oncology

Hyun Jung Yoon
Jieun Choi
Eunjin Kim
Sang-Won Um
Noeul Kang
Wook Kim
Geena Kim
Hyunjin Park
Ho Yun Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.951575

3,306 views
7 citations

Original Research

Published on 02 Sep 2022

Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations

in Thoracic Oncology

Chao Shi
Ruyue Xing
Mengmeng Li
Junnan Feng
Rui Sun
Bing Wei
Yongjun Guo
Jie Ma
Huijuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.949304

4,473 views
9 citations

Case Report

Published on 02 Sep 2022

PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review

in Thoracic Oncology

Na Yin
Xiangliang Liu
Xiaojun Ye
Wei Song
Jin Lu
Xiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.961266

2,573 views
5 citations

Systematic Review

Published on 02 Sep 2022

Acupuncture for adult lung cancer of patient-reported outcomes: A systematic review and meta-analysis

in Thoracic Oncology

Ziqi Xi
Xuqiang Wei
Zi Ye
Ke Wang
Jia Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.921151

9,210 views
10 citations

Original Research

Published on 31 Aug 2022

Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis

in Thoracic Oncology

Ke Zhou
Yaqin Zhao
Linchuan Liang
Jie Cao
Huahang Lin
Zhiyu Peng
Jiandong Mei

Frontiers in Oncology

doi 10.3389/fonc.2022.938195

2,181 views
8 citations

Navigation group

Articles

Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review

Drug-induced liver injury associated with dacomitinib: A case report

The combined role of PET/CT metabolic parameters and inflammatory markers in detecting extensive disease in small cell lung cancer

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases

A detection panel of novel methylated DNA markers for malignant pleural effusion

Pembrolizumab monotherapy for untreated PD-L1-Positive non-small cell lung cancer in the elderly or those with poor performance status: A prospective observational study

Use of savolitinib as neoadjuvant therapy for non–small cell lung cancer patient with MET exon 14 skipping alterations: A case report

Impact of the interval between neoadjuvant immunochemotherapy and surgery on surgical–pathological outcomes in non-small cell lung cancer

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy

EML4-ALK rearrangement in primary malignant fibrous histiocytoma of the lung treated with alectinib: A case report

Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study

Deep learning analysis to predict EGFR mutation status in lung adenocarcinoma manifesting as pure ground-glass opacity nodules on CT

Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations

PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review

Acupuncture for adult lung cancer of patient-reported outcomes: A systematic review and meta-analysis

Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis